Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk (NVO)
NYSE:NVO
Total Valuation
Novo Nordisk has a market cap or net worth of $213.72B. The enterprise value is $1.35T.
Market Cap$213.72B
Enterprise Value$1.35T
Share Statistics
Novo Nordisk has 3,390,128,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,390,128,000
Owned by Insiders―
Owned by Institutions0.05%
Financial Efficiency
Novo Nordisk’s return on equity (ROE) is 0.51 and return on invested capital (ROIC) is 28.46%.
Return on Equity (ROE)0.51
Return on Assets (ROA)0.18
Return on Invested Capital (ROIC)28.46%
Return on Capital Employed (ROCE)0.38
Revenue Per Employee3.84M
Profits Per Employee1.32M
Employee Count77,406
Asset Turnover0.57
Inventory Turnover1.12
Valuation Ratios
The current PE Ratio of Novo Nordisk is 14.4. Novo Nordisk’s PEG ratio is 8.49.
PE Ratio14.4
PS Ratio4.66
PB Ratio7.42
Price to Fair Value7.42
Price to FCF25.38
Price to Operating Cash Flow10.47
PEG Ratio8.49
Income Statement
In the last 12 months, Novo Nordisk had revenue of 297.20B and earned 98.50B in profits. Earnings per share was 23.06.
Revenue297.20B
Gross Profit240.66B
Operating Income123.04B
Pretax Income125.53B
Net Income98.50B
EBITDA153.18B
Earnings Per Share (EPS)23.06
Cash Flow
In the last 12 months, operating cash flow was 119.10B and capital expenditures -62.92B, giving a free cash flow of 56.18B billion.
Operating Cash Flow119.10B
Free Cash Flow56.18B
Free Cash Flow per Share16.57
Dividends & Yields
Novo Nordisk pays an annual dividend of $0.412, resulting in a dividend yield of 3.58%
Dividend Per Share$0.412
Dividend Yield3.58%
Payout Ratio35.14%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.17
52-Week Price Change-44.78%
50-Day Moving Average53.24
200-Day Moving Average58.51
Relative Strength Index (RSI)30.87
Average Volume (3m)20.22M
Important Dates
Novo Nordisk upcoming earnings date is May 6, 2026, Before Open (Confirmed).
Last Earnings DateFeb 4, 2026
Next Earnings DateMay 6, 2026
Ex-Dividend Date―
Financial Position
Novo Nordisk as a current ratio of 0.80, with Debt / Equity ratio of 67.49%
Current Ratio0.80
Quick Ratio0.57
Debt to Market Cap0.09
Net Debt to EBITDA0.69
Interest Coverage Ratio18.88
Taxes
In the past 12 months, Novo Nordisk has paid 27.03B in taxes.
Income Tax27.03B
Effective Tax Rate0.22
Enterprise Valuation
Novo Nordisk EV to EBITDA ratio is 10.18, with an EV/FCF ratio of 27.22.
EV to Sales4.99
EV to EBITDA10.18
EV to Free Cash Flow27.22
EV to Operating Cash Flow13.48
Balance Sheet
Novo Nordisk has $26.96B in cash and marketable securities with $130.96B in debt, giving a net cash position of -$104.00B billion.
Cash & Marketable Securities$26.96B
Total Debt$130.96B
Net Cash-$104.00B
Net Cash Per Share-$30.68
Tangible Book Value Per Share$14.39
Margins
Gross margin is 80.98%, with operating margin of 39.81%, and net profit margin of 31.87%.
Gross Margin80.98%
Operating Margin39.81%
Pretax Margin40.62%
Net Profit Margin31.87%
EBITDA Margin49.08%
EBIT Margin44.34%
Analyst Forecast
The average price target for Novo Nordisk is $58.83, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$58.83
Price Target Upside24.67% Upside
Analyst ConsensusModerate Buy
Analyst Count8
Revenue Growth Forecast18.71%
EPS Growth Forecast11.24%